Literature DB >> 25095885

Therapy for peripheral artery disease: gaps in treating patients with claudication.

Ryan J Mays1, Judith G Regensteiner2.   

Abstract

Entities:  

Keywords:  Editorials; exercise; peripheral arterial diseases; quality of life

Mesh：

Year:  2014        PMID： 25095885      PMCID： PMC4486000          DOI： 10.1161/CIRCULATIONAHA.114.011990

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  24 in total

1.  Endovascular intervention for treatment of claudication: is it cost-effective?

Authors:  Timothy M Sullivan; Monica S O'Brien-Irr; Linda M Harris; Hasan H Dosluoglu; Maciej L Dryjski
Journal:  Ann Vasc Surg       Date:  2010-08       Impact factor: 1.466

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 3.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.

Authors:  J I Weitz; J Byrne; G P Clagett; M E Farkouh; J M Porter; D L Sackett; D E Strandness; L M Taylor
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

4.  One-year cardiovascular event rates in outpatients with atherothrombosis.

Authors:  Ph Gabriel Steg; Deepak L Bhatt; Peter W F Wilson; Ralph D'Agostino; E Magnus Ohman; Joachim Röther; Chiau-Suong Liau; Alan T Hirsch; Jean-Louis Mas; Yasuo Ikeda; Michael J Pencina; Shinya Goto
Journal:  JAMA       Date:  2007-03-21       Impact factor: 56.272

5.  Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

6.  Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease.

Authors:  F A K Mazari; J A Khan; D Carradice; N Samuel; M N A Abdul Rahman; S Gulati; H L D Lee; T A Mehta; P T McCollum; I C Chetter
Journal:  Br J Surg       Date:  2011-10-21       Impact factor: 6.939

Review 7.  Assessment of functional status and quality of life in claudication.

Authors:  Ryan J Mays; Ivan P Casserly; Wendy M Kohrt; P Michael Ho; William R Hiatt; Mark R Nehler; Judith G Regensteiner
Journal:  J Vasc Surg       Date:  2011-02-18       Impact factor: 4.268

8.  Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Michael R Jaff; Michael W Steffes; Anthony J Comerota; Jonathan Ehrman; Diane Treat-Jacobson; M Eileen Walsh; Tracie Collins; Dalynn T Badenhop; Ulf Bronas; Alan T Hirsch
Journal:  Circulation       Date:  2011-11-16       Impact factor: 29.690

9.  Risk attitudes to treatment among patients with severe intermittent claudication.

Authors:  Anna Letterstål; Christina Forsberg; Pär Olofsson; Eric Wahlberg
Journal:  J Vasc Surg       Date:  2008-05       Impact factor: 4.268

10.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-03-21       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.